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ABSTRACT 
An appropriately designed sustained release dosage form is opted to be a major goal in solving the problems which arises regarding the 
targeting of a drug to a specific organ or tissue and for controlling its rate of delivery to the target site. The developmen t of oral sustained 
release system has proven to be a major challenge to formulation scientist due to their inability to restrain as well as localize the system at 
targeted areas of the gastrointestinal tract. Therefore the development of matrix type drug delivery system is promising option regarding the 
development of an oral sustained release system. There is availability of wide variety of polymers which helps the formulation scientist to 
develop sustained/controlled release products. The attractiveness of these dosage forms is increasing because of their awareness towards 
toxicity and ineffectiveness when administered by oral route in the form of tablets and capsules. Numerous advantages are provided by 
sustained release products over conventional dosage forms through optimizing various bio-pharmaceutics, pharmacokinetic and 
pharmacodynamics properties of drugs and finally leads to reduction in dosing frequency to such an extent that only once daily dose is required 
for therapeutic management with maximum utility of drug with reduction in both local as well as systemic side effects. They can cure or control 
diseased condition in shortest possible time with smallest quantity of drug to assure greater patient compliance. Polymer swelling, drug 
dissolution and its diffusion are the known mechanisms for drug release through polymer network. 
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The oral drug delivery system is the most widely preferred 
and convenient route of drug administration. Due to high 
patient compliance, cost effectiveness, least sterility 
constraints, flexibility in the design of dosage form and ease 
of production causes this route to be more preferable than 
others. In oral administration the drugs are to be protected 
by unstable biological environment including drug 
degradation in the GIT tract and first pass metabolism in the 
liver after oral administration before reaching the targeted 
sites. Various challenges which are faced by oral drug 
delivery system are dissolution, permeability and solubility. 
Several pharmaceutical techniques have been found to 
stabilize and solubilize the active compounds in the GIT but 
they all failed to attain controlled and targeted release of 
oral drug as they all are capable of giving immediate and 
quick release. These days traditional drug delivery system 
has been characterized by the immediate release and 
repeated dosing of drug. These two factors leads to risk of 
dose fluctuation, this causes the need of formulation with 
controlled release that is capable of maintaining a constant 
and uniform blood levels. Drug delivery is the act or process 
for the administration of pharmaceutical compound in order 
to achieve or provide a therapeutic effect in diseased 
human’s body. The pharmaceutical products which are made 
for the purpose of oral delivery mainly found in the form of 
immediate release type and conventional drug delivery 
systems, which are responsible for immediate release of 
drug for fast absorption. Thus Modified or Novel drug 
delivery systems have been formulated or manufactured for 
the improvement in the pharmacokinetic profiles of active 
pharmaceutical ingredients (APIs), patient compliance as 
well as causing reduction in side effects. The main objective 
or goal in designing these sustained release dosage form is 
to reduce frequency of dosing, increase the effectiveness of 
drug by the act of localization at the site where the drug has 
to act, reduce the amount of dose and to provide steady and 
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uniform delivery of drug. Predetermined patterns are 
determined already for the drug release in the 
gastrointestinal tract by the sustained release formulations. 
These formulations are well known for the continuous 
release of drug over extended period of time, therefore the 
use of hydrophilic polymer matrix is extensively used for 
formulating a sustained dosage form. The immediate release 
drug delivery system lacks dose maintenance, site target 
action and controlled release. The sustained release 
formulations acquire some swelling polymer or waxes which 
are the main necessities for controlling release rate [3, 5]. 
Drawbacks of Conventional Dosage Forms- The 
conventional drug delivery system is the classical methods 
for the delivery of the drug into the body. 
1. Poor patient compliance. 
2. The drug whose half- life is very short requires 
frequent dosing and ultimately leads to more chances 
of missing the dose. As the frequencies of drug 
administration depends on biological half-life and 
Mean Residual Time of drug.  
3. Drug targeting is not easy to achieve. 
4. To attain steady state condition becomes difficult 
because of the typical valley concentration appears due 
to frequent dosing. 
5. The unavoidable fluctuations in drug level 
concentration may give rise to under medication or 
over medication due to unpredictable drug release 
pattern [6]. 
6. The fluctuations in drug levels may lead to rise of 
adverse effects especially with the one whose 
Therapeutic Index (TI) is small. And these fluctuations 
come whenever overmedication occurs. 
Thus to overcome the drawbacks of conventional dosage 
form several technical advancements had led to the 
development of controlled and sustained drug delivery 
systems that could provide several number of therapeutic 
benefit. 
SUSTAINED RELEASE DRUG DELIVERY SYSTEM 
The therapy for chronic disease requires a repeated dose of 
the drugs to be administered. And for the drugs which 
possesses very short half- life are given several times a day. 
In order to get rid from this the development of sustained 
release dosage form is needed which helps in maintaining 
the therapeutic effective concentration of the drug over an 
extended period of time. The sustained release dosage form 
are the drug delivery system which are designed in order  to 
provide a prolonged therapeutic effect by continuously 
releasing the medication over an extended period of time 
after the administration of a single dose of a drug of tablet. 
The ultimate aim of the therapy is to possess the steady state 
tissue level which is therapeutically effective and non-toxic 
for an extended period of time. The design of the proper 
dosage form is an important factor in achieving, providing 
and accomplishing this goal. The maximum drug 
bioavailability can be attained by tending and attempting to 
attain a maximum rate and extent of drug absorption. 
Sustained release dosage forms are considered as the best 
way to optimize the delivery of medication which is the 
utmost parameter to achieve a measure of control of the 
therapeutic effect and reduces the in vivo fluctuation [16]. 
 
ADVANTAGES OF CONTROLLED RELEASE DOSAGE 
FORMS- 
Controlled release dosage forms belongs to the class of 
biologically active products from which the release of drug 
occurs in a planned, predictable as well as slower than 
normal manner for a prolonged period of time. 
1. Controlled release dosage form results in the prolongation 
of drug action at a predetermined level by the maintenance 
of a constant, effective, drug level in the body as the kinetic 
pattern of peak valley which results from controlled release 
drug administration gets stabilized. 
2. Minimization of adverse effects are seen with this dosage 
form due to less drug fluctuation as the release rate is 
already predetermined and its occurs in a constant way over 
an extended period of time. 
3. Spatial placement of a controlled dosage form helps in the 
localization of drug action to a diseased organ, tissue, site 
and even the receptor is possible. 
4. The main role of controlled release drug delivery is the 
achievement of target drug action by the use of carriers or 
chemical derivatisation to make the drug available to 
particular target that may be a tissue, cell or receptors. 
5. It is a suitable delivery system for drugs which are having 
a short biological half-life (3-4 hours) and which rapidly 
eliminate from the body. 
6. Reduction in drug toxicity occurs with this dosage form. 
Improvement in drug bioavailability is seen because of 
spatial control [3, 7]. 
RATIONAL OF SUSTAINED RELEASE DOSAGE FORM 
The basic rational of sustained release dosage form is to 
extend the duration of action of the drug ,to minimize the 
fluctuations in plasma level ,improved drug utilization ,less 
adverse effects., to reduce the frequency of the dosing and 
thus providing the uniform drug delivery. The main target by 
which sustained release delayed drug delivery system are 
able to show their well-defined action is by altering the 
pharmacokinetics and pharmacodynamics of 
pharmacologically active drug moieties by using novel drug 
delivery system or by doing the modification of molecular 
structure and physiological parameters inherent in a 
selected route of drug administration. The sustained drug 
delivery occurs when a polymer is combined with a drug or 
active agent such a way that the release from the bulk 
material is pre-designed and its release is also 
predetermined by the use of film forming polymer and 
enteric depending on its use respectively. Controlled and 
Sustained Release both are used in consistent and confusing 
manner. Both are used to represent separate drug delivery 
process. As the sustained release constitutes any dosage 
form that provides medication over an extended period of 
time and it shows that the system is able to provide some 
actual therapeutic control and that can be of a temporal, 
spatial nature or both. Sustained release system generally 
don’t attain zero order type release but they try to mimic 
zero order release by providing drug in a slow first order 
[9,17]. 
OVERALL FUNCTION OF SUSTAINED DOSAGE 
FORM- 
Sustained release systems can be used to protect the drug 
from degradation in the acidic environment i.e. low pH 
environment of the stomach from irritation by the drug. In 
such circumstances the drug release should be delayed until 
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and unless it reaches the small intestine. In order to achieve 
this mission the use of polymers are needed as an important 
measure to control the release and as film forming agent. 
The dosage form (For example – a tablet or the granules 
before tableting) can be coated with an appropriate polymer. 
The polymer dissolves as a dependent function of pH that is 
when the dosage form travels from the low pH environment 
which is found in the stomach to the higher basic pH 
environment of the small intestine. As the small intestine is 
having large surface area because of the presence of 
microvilli and it is the only the site of area where polymer 
coat dissolves. The use of Microencapsulation is the 
technique by which coating can be applied in a proper way 
to enhance the formulation of sustained release dosage form. 
Microencapsulation is the means of applying thin coatings to 
small particles of solids or droplets and dispersions. It is 
differentiated and different from macro coating in the means 
that the former involves the coating of particles ranging 
from several tenths of a micron to 5000 microns in size. It is 
the means of converting liquids to solids capable of changing 
colloidal and surface properties as well as controlling the 
release characteristics of coated materials. Along with this 
property they are also capable of masking the taste of 
tablets, powders, suspensions etc.  
Various techniques used for this purpose are Air suspension, 
Coacervation phase separation, Spray Drying and Spray 
Congealing [8] 
As the basic aim of sustained release dosage form is to 
achieve and maintain therapeutic blood level in a target 
system for an extended period of time at a constant level. 
This attempt usually tries to follow the zero order release 
from the dosage form. Zero order release comprises the drug 
release from its dosage form that is independent of the 
amount of the drug in the delivery system i.e. it does not 
depend on concentration and release is in constant manner. 
Sustained release systems in general do not attain this type 
of release and try to follow and mimic zero order release by 
continuously releasing the drug in a slow first order manner 
(i.e. concentration dependent) [11, 17].   
METHOD OF FORMULATION [6, 8]    
Sustained release dosage form may contain- 
 Maintenance Dose              
 Loading Dose  
Sustained release dosage form includes all drug delivery 
systems that achieve slow release of drug over an extended 
period of time. Basically a sustained release oral dosage 
form is designed to rapidly release pre-determined fraction 
of the total dose (loading dose) into gastrointestinal tract, 
which will produce the desired pharmacological response as 
promptly as possible and the remaining fraction of the total 
dose (maintenance dose) is then released at a controlled rate 
to maintain the steady state. The controlled release of the 
drug product is designed so that the release rate of 
maintenance dose is equal to the elimination rate. The 
constant blood levels can be achieved from controlled 
release system and the prolonged release of the dosage form 
reduces the fluctuation in plasma by slowing down its 
absorption rate so that its slower drug release rate can be 
achieved as well as can be maintained. The Maintenance 
dose also called as slowly available portion which will 
release the drug slowly and will maintain the therapeutic 
level for an extended period of time. The Loading dose is the 
immediately available portion which help in obtaining the 
therapeutic level quickly after administration. If the drug at 
the absorption site is to remain at constant rate then the rate 
of release of the drug from the maintenance dose should 
follow zero order rate. Zero order means the drug release is 
independent of initial concentration or amount of drug. The 
release of drug from the loading dose should follow first 
order rate release i.e. dependent on initial concentration of 
the drug [6, 8]. 
CLASSIFICATION OF SUSTAINED RELEASE DOSAGE 
FORM 
Sustained release drug delivery system can be considered as 
an effective advance toward solving the problem concerning 
drugs have a short half-life are eliminated quickly from 
blood circulation require frequent dosing. In order to avoid 
this problem oral sustained release formulations have been 
developed in an attempt to release the drug slowly into the 
g.i.t and maintain a constant drug concentration for long 
period of time. The Sustained release is a type of dosage 
form that releases the drug at a predetermined rate in order 
to maintain the constant drug concentration for a specific 
period of time with the minimum side effects. The sustained 
release dosage form can be classified as such [7- 10]. 
Continuous release system 
These are the systems which releases the drug for a 
prolonged period of time along the entire length of GIT tract 
with the normal transit of the dosage form. The various 
systems under this category is- 
(A). Diffusion sustained release system 
(B). Dissolution sustained release system 
(C). Dissolution and diffusion sustained release system 
(D). Ion Exchange resin- drug complex  
(E). pH dependent formulation 
(A). Diffusion sustained release system [11, 16] 
Diffusion systems are characterized by the release rate of a 
drug which is being dependent on its diffusion through an 
inert membrane barrier. In this type of systems the diffusion 
of dissolved drug occurs through a polymeric barrier which 
is a rate limiting step. The drug release can never occur at 
zero order. The diffusional path length of drug increases 
with time as the insoluble matrix gradually gets depleted of 
the drug. In these systems there is a water insoluble polymer 
which is responsible for the control of flow of water and the 
subsequent release of dissolved drug from the dosage form. 
Diffusion occurs when a drug passes through a polymer that 
forms the controlled release device. The diffusion can occur 
through the pores in the polymer matrix or by passing 
between the polymer chains. In this case the diffusion of the 
drug molecules serves the basis of these controlled drug 
delivery system. Diffusion process is defined as the 
movement of the molecules of drug from a region of higher 
concentration to a region of lower concentration. The 
diffusion controlled system are formulated either by these 
two methods i.e. Encapsulating the drug particles in a 
polymeric membrane or by dispersing the drug in a 
polymeric membrane.  
Types of Diffusion sustained release systems 
 Reservoir devices 
 Matrix devices 
 Erosion controlled devices [13]. 
Reservior Devices- In this type of system, water insoluble 
polymeric material encases a core of drug. The drug will get 
partition into the membrane and exchange with the fluid 
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surrounding the particle or tablet.The active drug agent will 
get released into the surrounding media environment by 
diffusion process through the rate limiting membrane. In the 
reservoir devices the drug delivery rate remains fairly 
constant. The additional drug will again enter the polymeric 
membrane then diffuses into the periphery and gets 
exchanged with the surrounding media. The drug release 
from this system takes place by diffusion process.  
Matrix Devices- A matrix system consists of active and 
inactive ingredients that are homogeneously dispersed and 
mixed in the dosage form. The drug is dispersed as the solid 
particles within a porous matrix formed of a water-insoluble 
polymer. The drug particles which are located at the surface 
of the release unit will be dissolved firstly and will release 
the drug release rapidly. Thereafter, drug particles at a 
successively increasing distance from the surface of the 
release unit will be dissolved and will release by the 
diffusion in the pores to the exterior of the release unit. 
Matrix can also be defined as well mixed composite of one or 
more drugs with gelling agent’s i.e. hydrophilic polymers. 
Matrix systems are widely used for sustaining the release 
rate. It is the release rate which prolongs and controls the 
release of the drug. Release from matrix type formulation is 
governed by Fick’s first law of diffusion [7-10]. 
Advantages of Matrix System  
Unlike reservoir and osmotic systems, products based on 
matrix design can be manufactured by using conventional 
processes and its equipment’s. Secondly, development cost 
and time associated with the matrix system generally are 
viewed as variables, and no additional capital investment is 
required. A matrix system is capable for accommodation of 
both low plus high drug loading and active ingredients by 
providing a wide range of physical as well as chemical 
properties [2-5]. 
These diffusion controlled systems are the type of rate 
programmed drug delivery system from which the drug 
release has been programmed at specific rate profiles. In 
these systems the rate controlling step is not the dissolution 
rate of drug or release controlling element but it is the 
diffusion of dissolved drug molecules through the rate 
controlling element. The rate controlling element in such 
types of the systems are insoluble, non-erodible and non-
degradable and therefore these are porous in their nature 
and allows the diffusion of dissolved drug. Thus they can be 
classify according to the mechanism by which their rate 
controlling element controls drug diffusion and these are 
divided two categories – 
Porous matrix controlled systems 
In these systems the rate controlling element is either a 
water swell able material i.e. hydrophilic polymers or gums 
such as guar gum, xanthan gum, high viscosity grades of 
hydroxypropyl methylcellulose (HPMC) and hydroxypropyl 
cellulose, alginates etc. or the non-swell able water insoluble 
polymer such as Ethyl cellulose. Various polymers are used 
for the maintenance of these systems which are listed below. 
 Properties of basic polymers used [8] 
 HPMC is considered as an ideal polymer for film 
coating but when used alone it has the tendency to 
bridge or fill the debossed tablet surfaces. The mixture 
of HPMC with other polymers or plasticizers is used to 
eliminate bridging and filling problems. It is also used 
in glossing solutions (Chauhan et al., 2012). 
 Ethyl cellulose is completely insoluble in water and 
gastrointestinal fluids and therefore it cannot be used 
alone for tablet coating. It is generally combined with 
water soluble additives e.g. HPMC in order to prepare 
films which is having reduced water solubility 
properties. The combination of ethyl cellulose with 
water soluble additives are most widely used for the 
preparation of sustained release tablets.  
 Povidone is a synthetic polymer consisting of linear 1- 
vinyl-2 pyrrolidinone groups. The degree of 
polymerization results in various molecular weight 
range. Povidone is usually available in four viscosity 
grades which are identified by their K values such as K-
15, K-30, K-60 and K-90. The average molecular weight 
of these are 10,000, 40,000, 160,000 and 360,000. The 
most important use of it as a tablet binder and in a 
tablet coating. It can be cross-linked with the other 
materials to produce films with enteric properties. 
 Porous membrane controlled systems  
These are those systems in which the rate controlling 
element is non-swell able water insoluble polymer such as 
ethyl cellulose or polymethacrylate which can control the 
drug release through the micro pores present in the 
membrane or matrix structure. In Matrix systems the drug 
active agent is present as a dispersion within the polymer 
matrix and they are usually formed by the compression of a 
polymer and drug mixture or by dissolution or melting [12.13]. 
Drug release properties from monolithic devices 
From an engineering point of view, the term “matrix” 
indicates a three-dimensional network, more often 
polymeric, fabricated for a particular application and 
containing an active agent (drug) and other substances such 
as solvents and excipients. There are three methods for the 
preparation of polymer monolithic systems. The first one is 
based on mixing the drug, as a thin powder, with the 
prepolymer and subsequently placing the whole mixture in 
the polymerization reactor. A matrix can be prepared in 
advance and then it is made to put in contact with a highly 
concentrated drug solution so that swelling of the matrix can 
occur. The solvent is then removed by a physical treatment. 
The second approach depends on mechanic-chemical 
activation, by which the loading of a drug is made into a 
polymeric carrier, thus helps in the avoiding the use of those 
solvents whose elimination is a very expensive and delicate 
operation. Supercritical fluid techniques is also used for drug 
loading in the matrices. The supercritical fluids are supposed 
to be dense as liquid but viscous as gas, and easily swell the 
matrix (bringing the drug inside the matrix or extracting 
solvents) and can be easily removed by decreasing pressure. 
These supercritical fluids are used when drug is not showing 
compatible with other polymers for the loading purpose. The 
simplest way for making or developing a monolithic system 
is to compress, the proper ratio of the polymer, drug and the 
excipients [15, 16]. 
CLASSIFICATION OF MATRIX TABLETS- 
(a) On the Basis of Retardant Material Used:  
Matrix tablets can be divided in to five types- 
1. Hydrophobic Matrices (Plastic matrices) – 
The idea of using hydrophobic or inert materials as matrix 
materials was first introduced in 1959. It is the method of 
obtaining sustained release effect from an oral dosage form 
in which the drug is mixed with an inert or hydrophobic 
polymer and then compressed into a tablet. Sustained 
release is produced due to the concept that the dissolving 
drug has diffused through a network of channels that are 
present between compacted polymer particles. Examples of 
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materials that are used as an inert or hydrophobic matrices 
include polyethylene, polyvinyl chloride, ethyl cellulose and 
acrylate polymers and their copolymers. The rate-
controlling step in these formulations systems is liquid 
penetration into the matrix. Hydrophobic matrix tablets are 
the most frequently and largely used as sustained release 
oral dosage forms intended for oral administration in which 
the very possible mechanism of release of drug from tablet 
matrix is diffusion. Hydrophobic matrix systems are mainly 
formulated by the use of waxes and can be suitable for drugs 
which have a high solubility. Wax based matrices have been 
explored to ascertain the factors that would affect the 
release of drug. Hydrophobic systems are the only systems 
where the use of polymer is not essential to provide the 
controlled release however the use of insoluble polymers 
can be used. The primary rate controlling elements of 
hydrophobic matrix are found to be water insoluble in 
nature. The required ingredients mainly are waxes 
glycerides fatty acids and the above mentioned polymers [11]. 
The drug release has been successfully modulated by the use 
of hydrophobic matrices as these matrices are based on 
waxes which can modify release rate by increasing the 
amount of drug or wax concentration, make the system also 
capable for incorporating hydrophilic polymers which helps 
in the enhancement of drug release by getting swell. On 
coming in contact with water a hydrophilic matrix increases 
in size due to the fact of entry of the solvent. Then this 
causes the polymer to swell up forming a barrier to drug 
release. The drug particles would then move through this gel 
layer by diffusion or erosion of the gel eventually allows the 
drug to get released. This type of systems are the type of 
monolithic matrix system which allows the drug to be 
encapsulated or dispersed in a matrix. To modulate the drug 
release it is necessary to add or incorporate the soluble 
ingredients such as lactose in the formulation. Diffusion of 
active ingredient from the system is the release 
characteristic of drug. The diffusion of the active ingredient 
from the system is the release mechanism, can be best 
explained by Higuchi equation which is also known as 
square root of time release kinetic. The square root of time 
release profile is thought to be with a porous monolith, 
where the release rate from such system is proportional to 
the drug loading. Additionally the hydrophobic matrix 
systems are not suitable and compatible for insoluble drug 
as the concentration gradient is too low for the adequate 
release of the drug to occur. While considering the 
formulation design, incomplete release of drug within the 
gastrointestinal tract time proves to be a potential risk and 
need to be focused and taken into account during the 
process of development [4-7]. 
2. Hydrophilic Matrices  
Hydrophilic matrix tablets are the most frequently used 
sustained release oral dosage forms intended for oral 
administration. The primary rate limiting step is that the 
polymers would swell when it comes into contact with water 
and forms a gel layer on the surface of the system. When the 
release medium is thermodynamically compatible with a 
polymer then the solvent gets penetrated into the free 
spaces present between the chains of the macromolecules. 
The polymer undergoes a relaxation process due to the 
stress of the penetrated solvent. This relaxation process 
causes the polymer chains to become more flexible and the 
matrix swells as well as it also allows the encapsulated drug 
to diffuse more rapidly out of matrix. Hydrophilic matrix can 
be formulated by the method of wet granulation of the drug 
and hydrophilic matrix materials or by the use of the direct 
compression of the blended mixture of active ingredient 
with certain hydrophilic carriers. The hydrophilic matrices 
offer several advantages such as ease of the manufacture, 
cost effectiveness, uniformity of matrix tablets and broad 
regulatory acceptance. The best choice regarding the use of 
the hydrophilic polymers in matrix tablet is its capability for 
matrix building material with fast polymer hydration 
capability. An insufficiency in the polymer hydration rate 
may cause premature diffusion of the drug and easy 
disintegration of the tablet because of the faster penetration 
of water. But on the other hand the drug release process 
could take more time to diffuse out of the matrix as matrix 
swelling lengthens the diffusion path. Various factors which 
can determine the drug release from the dissolvable matrix 
are [12, 13]. 
 Swelling 
 Diffusion 
 Polymer dissolution [11]. 
This polymer dissolution is another important factor which 
has to be taken into consideration from this hydrophilic 
matrix and can modulate the drug delivery rate. In the most 
drug release kinetics the two predominant factors for 
specific type of polymers are the swelling and dissolution. 
The presence of water decreases the glass transition 
temperature which in turn gives rise to the transformation 
of glassy polymer to rubbery phase i.e. gel layer [11, 13]. 
Glass Transition Temperature- The glass transition 
temperature is an important property while considering 
polymers for a particular use. It is the temperature below 
which the physical properties of polymers changes into 
those of glassy or a crystalline state. Above which they 
behave like rubbery materials. As in hydrophilic matrix the 
use of HPMC is done to provide swell able properties. The 
glass transition temperature for HPMC is from 184 degree 
Celsius to below 37 degree Celsius. The presence of water 
decreases the glass transition temperature thus giving the 
rise to rubbery phase of polymer that is the gel layer. 
Favoring of the transportation of dissolved drug is 
developed by the enhanced motility of the polymeric chain. 
The Swelling or the volume increase of the matrix is 
determined by the polymer relaxation mechanism. The main 
polymers which are used in the preparation of hydrophilic 
matrices are Hydroxypropyl methylcellulose, hydroxypropyl 
cellulose, carbopol, alginates and xanthan gum [10, 11]. 
The hydrophilic matrices has most widely gained acceptance 
in the use of sustained drug delivery because of their cost 
effectiveness, flexible nature and it is also accepted on 
regulatory basis. Formulation of the drugs in the gelatinous 
capsules uses hydrophilic polymers which has high gelling 
capacities which are used as base excipients are of particular 
concern in the field of sustained release. Thus Matrix can be 
defined as well mixed composite of one or more drugs with 
the use of gelling agent i.e. hydrophilic polymer and 
therefore these systems are called as swell able sustained 
release systems.   
3. Fat-wax matrix tablet 
The drug can be incorporated into fat wax granules by the 
method of the spray congealing in the air, blend congealing 
in an aqueous media with or without the need of the 
surfactant and spray drying techniques. By the technique of 
bulk congealing method, a suspension of drug and melted fat 
wax is allowed to solidify and then it is allowed for 
comminuted in order to obtain the sustained-release 
granulations. The mixture of active ingredients, waxy 
materials and other additives can also be converted into 
granules by compacting with the use of roller compactor and 
then heating in a suitable mixture such as fluidized – bed and 
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steam jacketed blender or granulating it with a solution of 
waxy material or other binders. Hydrolysis, leaching and 
dissolution of fats under the influence of enzymes serve as 
the important characteristics tool for the drug release which 
is embedded into the melt of fats and waxes. These matrices 
prepared by the lipid waxes and other related materials. 
Drug release from such matrices can also follow the both 
pore diffusion and erosion. Release characteristics are 
therefore said to be more sensitive to digestive fluid 
composition than to totally insoluble polymer matrix. 
Carnauba wax in combination with stearyl alcohol or stearic 
acid has been commonly used for the retardant base of many 
sustained release [10, 11]. 
4. Biodegradable matrices  
These matrices consist of the polymers which are composed 
of monomers that linked to one another with the help of the 
functional groups and pursue an unstable linkage in the 
backbone. It is degraded or eroded biologically by the help of 
enzymes which are produced in the living cells or by non – 
enzymatic process into the formation of oligomers and 
monomers that can be easily metabolized or excreted from 
the body. Examples includes the natural polymers such as 
proteins, polysaccharides, modified natural polymers and 
synthetic polymers such as aliphatic polyesters, poly 
anhydrides, polycaprolactone etc. 
5. Mineral matrices  
These type of matrices are consist of polymers which are 
obtained and found from various species of seaweeds. 
Example include alginic acid which is a hydrophilic 
carbohydrate obtained from species of brown seaweeds 
with the use of dilute alkali [10, 11]. 
Mechanism of drug release from the matrix system  
The drug in the outside layer is exposed to the bathing 
solution is dissolved first and then diffuses out of the matrix. 
This process continues with the interface between the 
bathing solution and the solid drug which is moving toward 
the interior. It follows that for this system to be diffusion 
controlled, the rate of dissolution of drug particles within the 
matrix must occur at much faster than the diffusion rate of 
dissolved drug leaving the matrix. In a hydrophilic matrix, 
there are two opposite mechanisms are responsible for the 
drug release: Fickian diffusional release and relaxation 
release. Diffusion is not the only way by which a drug is 
released from the matrix; the erosion of the matrix following 
polymer relaxation contributes to the overall release. (a).The 
swelling front- As the water enters into the matrix, the 
polymer undergoes passage   from the crystalline state to a 
hydrated or gelified state. 
(b).The erosion front or dissolution front-This point 
separates the gelified zone from the matrix of the solvent. 
c). Diffusion front (solid drug–drug solution boundary) - 
This is located between the swelling and erosion fronts and 
is responsible for the separation of the zone of the gelified 
matrix which is containing the drug dissolved in the medium 
from the zone of the matrix containing the undissolved solid 
drug [5-7]. 
The relative contribution of every component reflects their 
role to the total release and it is primarily dependent 
relative on the properties of a given drug.  For example, the 
release of a sparingly soluble drug from hydrophilic matrices 
follows the immediate absorption of water and therapeutic 
activity of drug by a swelling-controlled diffusion 
mechanism. When the water penetrates into a glassy 
polymeric form of the compound matrix, the polymer swells 
and its glass transition temperature is lowered. At the 
constant time the dissolved drug diffuses through this 
swollen rubbery region into the external dissolution 
releasing medium. This type of diffusion and swelling does 
not basically follows this Fickian diffusion mechanism. 
Solvent diffusion into polymers is central to their 
performance in the controlled delivery pharmaceutical 
products. HPMC is a polymer commonly used in the 
production of tablets to control the release of the drug. A 
layer of hydrogel is formed by polymer hydration and chain 
relaxation when the tablet coating is in contact with water. 
This layer represents a barrier that retards processes of 
further water uptake and of drug release. Swelling-
controlled systems basically composed of a uniformly 
dispersed or distributed drug within a biodegradable and 
swell able polymer. These swell able polymers are 
hydrophilic in nature so that when in contact with water, the 
latter is absorbed into the polymer, thereby swelling the 
polymer matrix. The swelling helps in loosening the polymer 
entanglement leading to disentanglement of the polymer. 
The polymer matrix swelling leads to the formation of a 
rubbery region, in which there is better drug mobility due to 
lower polymer concentration. This helps in the enhancement 
of release characteristics of the drug which not only depends 
on the diffusion rate of the drug but also on the polymer 
disentanglement and dissolution processes [12, 15]. 
Erosion controlled devices- The biodegradable polymers 
are mixed with drug or active agents in this system. With the 
access of natural biological processes the materials undergo 
degradation and the release of drug occurs at the constant 
rate. Hydrolysis plays a pivotal role in the degradation of 
biodegradable polymer chains into biologically acceptable 
smaller compounds. The release of drugs is mainly 
controlled by the controlling rate of the polymer matrix. 
Erosion is mainly defined as the physical disintegration of a 
polymer matrix coating by the result of degradation and it 
can be characterized by the loss of polymer material from 
the surface generally in the physical state. The main causes 
of the degradation or hydrolysis of the polymer chains which 
are entangled are the osmotic pressure, hydrodynamic 
pressure i.e. the pressure exerted by excipients that imbibe 
water and undergoes swelling, enzymes, change in pH and 
finally causes fragmentation [12, 15]. 
Depending on the erosion mechanism polymers can undergo 
two types of erosion 
Surface erosion -The erosion occurs from the surface layers 
of the device and the gradual decrease in the size of the 
device occurs but the bulk phase of the system remains 
unchanged and undegraded. This process is also called as 
the heterogeneous erosion because the difference in the 
erosion rate between the surface and the center of the 
matrix occurs [12]. 
Bulk erosion – The erosion occurs throughout the bulk of 
polymer and therefore this process is also known as 
homogenous erosion. Bulk erosion occurs when the water 
penetration is readily to occur or is easily able to penetrate 
the matrix of the system [15]. 
(B). Dissolution Sustained System 
A drug with a slow dissolution rate will effectively show the 
sustaining properties as the release of the drug will get 
limited by the rate of dissolution. Sustained release 
preparation of drugs can be formulated by making their rate 
of dissolution to be lowered or decreased. The approaches to 
achieve this sustained effect includes the preparation of the 
appropriate salts or derivatives and coating the drugs with 
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slowly dissolving materials called polymers or incorporating 
it into a tablet with the use of a slowly dissolving carrier. 
These systems are most commonly used in the formulation 
of enteric coated dosage forms. To protect the stomach from 
the effects of drugs such as aspirin, a coating that gets 
dissolved in the alkaline media is commonly employed. This 
results in the inhibition of the release of drug from the 
device until it reaches the site of higher pH of the intestine. 
In most of the circumstances an enteric coated dosage forms 
are not truly showing sustaining effect but still serve as a 
useful function in directing release of the drug to a special 
site [6, 15]. 
Types of dissolution sustained release drug delivery 
system 
Reservoir type- The drug is coated with a given thickness of 
the coating, which gets slowly dissolved in the contents or 
substances of gastrointestinal tract. By doing alternation of 
the layers of drug with the rate controlling elements, a 
pulsed delivery can be achieved. If the outer layer is quickly 
releasing bolus dose of the drug then initial levels of the 
drug in the body can be quickly established with pulsed 
intervals. An alternative method is to administer the drug as 
a group of beads that acquires the coating of different 
thickness. As the beads have different coating thickness 
therefore their release takes place in a progressive manner 
Matrix Type- These are common type of dissolution 
sustained dosage form. Here the drug can be either in the 
form of the impregnated sphere or a drug impregnated 
tablet which will be subjected to slow erosion. Two types of 
dissolution sustained pulsed delivery systems.  
 The Single bead type device with alternating drug and 
rate-controlling layer.  
 The Beads containing drug with different thickness of 
dissolving coats.  
Amongst the sustained release formulations the 
hydrophilic matrix technology is the most widely used 
and preferred drug delivery system due to following 
advantages-  
 It provide desired release profiles for a wide 
therapeutic drug category, dose and solubility [1, 2]. 
 It is simple and cost effective manufacturing using 
existing tableting unit operation equipment. Occupies 
broad regulatory and patient acceptance. 
  The ease of modulating drug release is possibly 
guaranteed through level and with the choice of 
polymeric systems and function coatings. 
(C). Dissolution and diffusion sustained release system 
In these systems the rate of drug release is controlled by the 
dissolution of drug as dissolution are responsible for the 
creation of the pores in the partially soluble membrane. The 
pores which are formed by this process of dissolution allows 
the entry of aqueous medium into the core which is 
composed of drug. Thus drug dissolution is the main 
enforcement factor for the diffusion of dissolved drug out of 
the system. These systems are combination of two or more 
processes. The use of non-swell able and swell able 
polymers used for the development of this system as they 
are composed of reservoir and matrix system. The non-swell 
able polymers used for this purpose are Ethyl cellulose and 
polymethacrylate as these systems are capable of controlling 
the release of drug owing to their factors such as thickness, 
insolubility or slow dissolution or porosity. The best 
example for the swelling purpose is hydroxyl propyl 
cellulose (HPMC) polymers as they are capable of forming 
hydration barrier for the constant release of drug [1, 2]. 
Mechanism of drug release from dissolution controlled 
system 
The drug with slow dissolution rate can show the sustaining 
properties as the discharge of the drug will be limited by the 
rate of dissolution. In reality it is possible to prepare 
extended release products by decreasing the dissolution rate 
of drugs that are highly water soluble. Coating of the drug 
with a gradually dissolving material – encapsulation 
dissolution. Incorporation of the drug as a tablet in a slowly 
dissolving carrier matrix can help the dissolution to get 
manage. But the major disadvantage is that the drug release 
rate continuously decreases with time. The dissolution 
method can be depicted as the diffusion-layer-controlled. 
The rate of diffusion from the solid surface to the bulk of the 
solution through an unstirred liquid film is considered to be 
rate-determining step. The dissolution release rate occurs at 
steady-state can be well described by the Noyes-Whitney 
equation [8]. 
(D). Ion- Exchange resin drug delivery system 
Ion-exchange systems make use of resins composed of 
water-insoluble cross-linked polymers. These used polymers 
are constituted of the salt-forming functional groups in 
repeating positions on the polymer chain. The drug is bound 
to the resin and gets released by exchanging with 
appropriately charged ions in contact with the ion-exchange 
groups.  
Anion Exchangers - Resin+ - Drug- + Cl- goes to Resin+- Cl-
+ Drug-  
Cation Exchangers - Resin-- Drug+ + Na+ goes to Resin- - 
Na+ + Drug+ 
The ion exchange resins are mostly cross linked water 
insoluble polymers which are carrying functional groups 
present in their ionisable form. The resins are used in 
numerous pharmaceutical applications mainly for the 
establishment of controlled release dosage form and taste 
masking systems. The resin forms the irreversible complex 
with ionisable drugs and resin bound drug has to be 
removed when appropriate ions are already in contact with 
ion exchanged groups. In addition to these functions resins 
are employed as they are capable to disintegrate because 
they are having ability to swell. The rate of drug diffusion 
out of the resin is controlled by three factors- 
 Area of the diffusion which the drug has to travel for 
absorption. 
 The path length of diffusion.  
 Rigidity of the resin which is the major factor in the 
amount of cross-linking agent used to prepare the 
resin. For the better release mechanism from this 
system is to apply coating on the ion-exchange resin 
with the use of hydrophobic rate-limiting polymer i.e. 
by the use of microencapsulation process [10, 14]. 
 (E). pH-independent formulation  
As most of the drugs are either weak acids or weak bases the 
release from sustained release (SR) formulations is pH-
dependent. But the addition of the buffers such as salts of 
amino acids, citric acid, phthalic acid, phosphoric acid or 
tartaric acid can be added to the formulation in order to help 
to maintain a constant pH therefore rendering pH-
independent drug release. A buffered sustained release 
formulation can be prepared or formulated by mixing a basic 
or acidic drug with one or more buffering agent, granulating 
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with the use of an appropriate pharmaceutical excipients 
and coating with polymer that is permeable to 
gastrointestinal fluid. When this fluid penetrates through the 
membrane then the buffering agents adjust the fluid which 
comes inside in the polymer coating to suitable constant pH 
thereby rendering a constant rate of drug release [14]. 
Role of polymers in sustained dosage form- 
The use of polymers is inseparable part of sustained dosage 
form. The first polymeric devices developed for controlled 
drug release system was done in 1960. The polymer based 
controlled drug delivery systems are generally classified as 
Reservoir Membrane Devices and Matrix Monolithic Devices 
.In both of these the drug release is controlled by the 
polymeric membrane that surrounds the drug moiety. These 
polymeric membranes can be sub categorized into 
nonporous, micro porous, hydrophobic, hydrophilic 
substances like hydrogels and water swollen polymers. 
Various kinds of cellulose materials are developed for this 
purpose enhancement like cellulose triacetate, 
polycarbonate and polypropylene. These polymers help in 
the formation of membranes with the diameters of the order 
1.5×10-3   µm to several microns. In transdermal drug 
therapy the use of polyacrylate, vinyl polymers, 
polyurethane and cellulose derivatives are used commonly. 
Both acrylic and cellulosic polymers are used as film forming 
agents which allow the formation of tough protective 
coatings. The availability of chitosan as a film forming agent 
permits it wide use in the formulation of film dosage form. 
Before casting into films chitosan can be dissolved in organic 
acids such as lactic acid and acetic acid. For the direct 
compression tableting process Starch acetate (SA) polymer 
has been discovered as a novel and multifunctional 
excipient. Materials such as fibrinogen, fibrin and collagen 
have been investigated as suitable carriers for novel drug 
delivery system.  In the terms of non-toxicity and 
biocompatibility to most tissues the collagen has efficient 
structural, physical, chemical and immunological properties 
that can be easily altered. The drug release rate is influenced 
by factors such as diffusion across the membrane, tablet 
coating so that polymer doesn’t undergo two factors during 
its lifetime i.e. dissolution and degradation [11, 13]. 
THE MECHANISM OF SWELLING, EROSION AND 
DRUG RELEASE FROM HYDROPHILIC POLYMERS  
The three steps which are involved in the drug release from 
hydrophilic polymers are the following as the present 
research study and thesis work also deals with the usage of 
these polymers- 
(1). Polymer Swelling 
(2). Drug dissolution 
(3). Matrix Erosion  
When the drug loaded with swell able cellulose ethers based 
on hydrophilic matrices are exposed to dissolution fluid then 
the steep water concentration gradients are developed 
between the dissolution fluid and the outermost surface of 
matrix tablet. This lead to the water imbibition into the 
polymer matrix network. When the dry matrix tablets are 
introduced into the liquid system the diffusion coefficient 
tends to be very low as compared to the highly swollen gels 
where it is of the same magnitude as pure water. Thus the 
liquid acts as a plasticizer and the glass transition 
temperature reduces from 154 – 184 °C to around the 
system temperature 37 °C. As the glass transition 
temperature becomes equal to the temperature of the 
system the polymer chains starts to undergo relaxation and 
finally takes the suitable form of disentanglement therefore 
increasing the molecular surface area. This phenomena of 
the polymer chain relaxation is called as the Swelling. 
Swelling plays an important role in the release of drug. 
Polymer Swelling- When the polymer chain undergoes 
disentanglement after their glass transition temperature 
becomes equal to the temperature of system then the 
swelling of the polymer occurs which results in the increase 
of the molecular surface area. At this point the   continuous 
inward ingression of liquid causes breakage of  the hydrogen 
bonds formed during tablet compaction and can lead to the 
development of new hydrogen bonds accommodating water 
molecules. Thus the reduction in transition temperature and 
the formation of new hydrogen bonds leads to the swelling 
of polymer chains. As a result, a thick gelatinous layer forms 
on the surface of matrix tablets commonly known as a gel 
layer as MC/HPMC pass from the amorphous glassy state to 
the rubbery state and forms the gel like layer [2, 5].   
The transition temperature of HPMC can become lowered up 
to 40 degrees Celsius by the reduction of hydroxyl propyl 
molar substitution. At the lower temperature the polymer 
chains undergo hydration and become dehydrated as the 
temperature increases. Therefore the glass transition 
temperature gives information about the nature of the 
polymer and it is defined as the temperature when a 
thermoset polymer goes from an amorphous rigid state to a 
more flexible state. The normal state of polymers usually 
occurs in the amorphous solid form at the room 
temperature. In case of HPMC the glass transition 
temperature increases as the methoxyl and hydroxypropyl 
content ratio decreases and causes loss of hydrogen bonding 
network between cellulose. And finally it leads the polymer 
molecules to get locked into rigid amorphous structure due 
to short chin length and molecular chains do not have 
enough energy present in them to make them to move 
around. But as the glass transition temperature decreases 
there is a formation of new hydrogen bonds which results in 
swelling of the polymer chains and eventually leads to 
increase in surface area.  
On the basis of the development of the gel layer the matrix 
tablet gets divide into three distinguishable regions- 
1). Erosion Front- It is the highly swollen outer region which 
consist of the highest amount of water molecules but is 
considered to be weak in terms of the mechanical strength. 
And this layer acts as a diffusion barrier which serves the 
function of prevention of water penetration into the other 
two regions. 
2). Dissolution Front- It is the middle region and is 
considered to be moderately swollen and has relatively 
more strength than the outer one.  
3). Swelling Front- It is the innermost region and forms the 
core of the tablet which remains dry and has the capacity to 
maintain its glassy state for a longer period of time 
4). Penetration Front- This layer exists between the 
dissolution and swelling front and is responsible for adding 
further complexity to the system. 
The gel layer grows continuously time as the water 
penetrates into the matrix tablet. The polymer chains 
present on the surface of matrix tablet hydrate quickly as 
compared to those which are present inside the core and 
contact with the liquid causes chain relaxation (swelling) 
which causes the erosion of the matrix. Instantaneously, the 
outermost layer becomes fully hydrated and relaxation 
occurs which causes the disentanglement of polymeric 
chains which means breakage of the polymeric network 
which is responsible for the sustaining action of the drug.  
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Consequently the matrices start to dissolve from their 
surface as water continuously permeates towards the core. 
The relative rates of liquid uptake and erosion of a polymer 
matrix play a critical role in controlling the rate of drug 
release. The swelling, matrix erosion, drug release 
mechanisms are dependent on the concentration, degree of 
substitution and the polymer chain length of HPMC. It has 
the capacity to hydrate quickly to form a gel layer before the 
drug entrapped in the tablet matrix can dissolve. The 
Two processes which are involved in the dissolution of 
hydrophilic matrix tablets which can further lead to polymer 
erosion are the following- 
 Disentanglement of the polymer chains which are 
present at the surface of matrix tablets. 
 Second step involves the subsequent transport of the 
core drug into the surrounding medium or bulk 
solution after disentanglement. 
The physical entanglement of the polymer chains makes the 
polymer as well as the drug core to get rid or to become 
safer from the dissolution process itself. But with the 
passage of the time as the polymer remains no longer 
stronger and reduces its structural integrity the dissolution 
of the polymer which is present at the outer surface takes 
place by the bulk dilution medium present in the 
surrounding [13,17]. 
Both MC and HPMC are water soluble and as the water 
penetrates into the hydrophilic matrix, the polymer chains 
become hydrated and they start to disentangle from the 
matrix because MC and HPMC contains the linear 
hydrophilic polymeric chains which do not chemically cross-
link but instead of it forms the gelatinous layer on the 
surface of the tablets that is vulnerable to matrix erosion. At 
high polymer concentrations, the linear polymer chains 
entangle to form a physically cross-linked structure, which 
finally erodes and resulting in the liberation of polymer and 
drug molecules. However, the rate of polymer erosion is 
dependent on the viscosity of the MC/HPMC grade which are 
used in the formulation. Tablets which are fabricated from a 
high molecular weight and viscosity grade MC/HPMC show 
more resistance to polymer erosion than the low molecular 
weight and low viscosity grades. 
VARIOUS FACTORS AFFECTING DRUG RELEASE 
FROM THE POLYMER MATRIX LAYER [10, 16] 
The drug release kinetics are affected by various kinds of 
factors described as such as polymer swelling, drug 
diffusion/ dissolution, polymer erosion, drug distribution 
inside the matrix and the geometry of the system in which it 
is arranged i.e. cylinder or sphere shape. Besides these 
factors drug/polymer ratio also plays an important role in 
affecting these release characteristics.   
(A). Drug solubility 
 The water solubility of drug and molecular size is an 
important factor which plays an important role in the 
release of drug from swelling and erosion controlled 
polymeric matrices. For drugs which are having reasonable 
aqueous solubility, in these cases release of water soluble 
drugs occurs by dissolution in infiltrating medium and the 
release of poorly water soluble drug occurs by both 
dissolution of drug and dissolution of drug particles through 
erosion of the matrix tablet [16]. 
(B). Polymer hydration 
It is essential to study polymer hydration/swelling process 
to know the maximum number of polymers and polymeric 
combinations. The more important step in polymer 
dissolution include absorption/adsorption of water in more 
accessible places, rupture of polymer-polymer linking’s with 
the simultaneous forming of water-polymer linking’s, 
separation of polymeric chains, swelling and finally 
dispersion of polymeric chain in dissolution medium [17]. 
(C). Polymer diffusivity 
The diffusion of small molecules from polymer structure is 
considered to be energy activated process in which the 
movement of diffusant molecules occurs from a successive 
series of equilibrium position when sufficient amount of 
energy of activation for diffusion has been obtained by the 
diffusant molecules and in turn this depends on length of 
polymer chain segment, cross linking and crystallinity of 
polymer. The release of drug may be attributed to the mainly 
two factors [6, 13]. 
(1). Polymer viscosity- As it is a simple phenomenon that 
increasing molecular weight or viscosity of the polymer 
causes increase in the gel layer viscosity, which is formed 
when water hydrates the drug matrix system when it comes 
in contact with the dissolution medium in the GIT layer. 
(2). Polymer concentration- An increase in the polymer 
concentration causes an increase in the viscosity of gel layer 
and further causes increase in the diffusional pathway of the 
drug. This could cause a decrease in the effective diffusion 
coefficient of the drug and finally leads to reduction in the 
drug release. And this is the utmost reason which serves as 
an important pathway for the sustained effect of the drug 
[13]. 
(D). Thickness of hydrodynamic diffusion layer 
The drug release profile is a function of the variation in 
thickness of the hydrodynamic diffusion layer on the surface 
of matrix type delivery devices. As the thickness of 
hydrodynamic diffusion layer increases the magnitude of 
drug release value also decreases proportionality [10, 16]. 
(E). Drug loading dose 
The release kinetics is significantly affected by loading dose 
of the drug. The effect of the initial drug loading of the 
tablets on the resulting release kinetics thought to be more 
complex in the case of poorly water soluble drugs. With 
increasing initial drug loading the relative release rate first 
decreases and then increases, whereas, absolute release rate 
monotonically increases. In case of the freely water soluble 
drugs the porosity of matrix upon the principle of drug 
depletion increases with increasing initial drug loading [10, 
16]. 
(F). Surface Area 
Both the in vitro and in vivo rate of the drug release are 
observed to be dependent upon the surface area of dosage 
form. The release rate of drug from small tablet is faster as 
compared to large cylindrical tablets [16]. 
(G). Effect of diluent- 
The effect of diluent or filler is totally dependent on the 
nature of diluent. Water soluble diluents like lactose cause 
marked increase in drug release rate and release mechanism 
is also shifted towards Fickian diffusion and therefore they 
are added with the hydrophobic matrices tablets. But while 
in the case of the insoluble diluents like dicalcium phosphate 
reduce the Fickian diffusion and increase the relaxation 
(erosion) rate of matrix. The reason behind this is that water 
soluble filler in matrices stimulate the water penetration in 
to inner part of matrix because of its hydrophilic nature 
which leads to increased drug release rate [10, 16]. 
Sharma  et al                                                                                                        Journal of Drug Delivery & Therapeutics. 2019; 9(3-s):913-923 
ISSN: 2250-1177                                                                                  [922]                                                                                      CODEN (USA): JDDTAO 
ROLE OF NATURAL GUMS IN CONTROLLED 
RELEASE DOSAGE FORMS 
Due to great need and demand in drug delivery systems the 
excipients are included in novel dosage forms to fulfil 
required functions regarding the dosage form and these 
gums directly or indirectly influences or affects the rate and 
extent of drug release as well as their absorption in the GIT. 
Therefore the plant based and natural products demand the 
replacement of synthetic additives with these natural gums. 
Today, the whole world’s interest is lying in these natural 
drugs and excipients. These natural materials have many 
benefits over synthetic ones because these are chemically 
inert, nontoxic, less expensive and biodegradable [4, 8]. 
1).Tamarind Seeds  
Tamarind xyloglucan is found in the endosperm of the seed 
of the tamarind tree, Tamarindus indicia (family Fabaceae). 
The polysaccharide which is obtained from tamarind seeds 
has found use in formulating matrix tablets by the wet 
granulation technique and they were evaluated for its drug 
release characteristics. The different concentrations of the 
polymer were used for the preparation of tablets. Increase in 
polymer content causes the decreased release of drug. These 
polysaccharides serve as a biodegradable carrier for colon 
specific dosage forms. It was found that the matrix tablets 
which were formulated by using tamarind gum were able to 
carry most of the drug to the colon and restrict the release in 
upper GIT [4, 8]. 
2).Hibiscus Mucilage  
The fresh leaves of Hibiscus rosa-sinensis are responsible 
for the extraction of mucilage which is responsible for 
sustained action. (Family: Malvaceae). Mucilage of Hibiscus 
rosa-sinensis contains various chemical constituents such as 
L-rhamnose, D-galactose, D-galacturonic acid, and D-
glucuronic acid. The use of its mucilage has been reported 
for the development of sustained release tablets [4, 13]. 
3).Fenugreek Mucilage 
Mucilage is found from the seeds of Trigonella foenum-
graceum (family: Leguminosae).Seeds are responsible for 
containing a high percentage of mucilage which do not 
dissolve in water but form viscous and tacky mass which 
undergoes swelling when exposed to fluids. Gum contains 
various chemical constituents’ mannose, galactose, and 
xylose which are responsible for prolonged action of drug. 
The mucilage which is obtained from fenugreek was found 
to be better release retarding agent as compared to 
hypromellose at equivalent content [4, 13]. 
4).Neem Gum 
Neem gum is obtained from the trees of Azadirachta indica 
whose family is Meliaceae. The gum comprises of various 
constituents such as mannose, glucosamine, arabinose, 
galactose, fucose, xylose, and glucose. Studies were 
performed on the neem gum for the evaluation of its binding 
property as well for sustained release property. Results 
indicated that as the proportion of Azadirachta indica fruit 
mucilage increases, the overall time for the release of drug 
from the matrix tablet also gets increased [4]. 
5).Aloe Vera Mucilage 
Aloe mucilage is produced from the leaves of Aloe 
barbadensis which belongs to family Liliaceae. It contains 
arabinan, arabinorhamnogalactan, galactogalacturan, 
glucogalactomannan, galactoglucoarabinomannan and 
glucuronic acid containing polysaccharides which show 
good response in extended release dosage form. A controlled 
delivery system of glibenclamide, anti-diabetic drug was 
studied using aloe mucilage. The swelling behaviors with in 
vitro release rate characteristics were also undergone 
investigation. The dissolution study proved that the dried 
Aloe barbadensis leaves dried mucilage can be satisfactorily 
used as a matrix forming material for the controlled release 
of glibenclamide matrix tablets [4]. 
6).Guar gum 
Guar gum is obtained from the seeds endosperm of the 
legume plant known as Cyamopsis tetragonolobus. It is 
chemically composed of sugars as it is belongs to a variety of 
polysaccharides namely mannose and galactose. Guar gum is 
found to be more soluble than locust bean gum and founds 
to be better emulsifier than it as it is composed of more 
galactose branch points. Its degradation occurs extremes of 
temperature as well as pH such as pH 3 at 50°C. Stability of 
guar gum is found in the solution over pH range of 5-7. The 
strong acids are responsible for its degradation, hydrolysis 
and loss of viscosity. Higher concentration of alkalies also 
causes reduction in viscosity of guar gum. It is widely used 
for the purpose of thickener in cosmetics, pharmaceutical 
dosage forms. In an attempt made for the sustained release 
tablets of furosemide, combination of pectin, xanthan gum 
and guar gum were used for it. In vitro release of drug in 
phosphate buffer of pH 7.4 was performed and extended 
action of drug was found up to fifteen hours. In addition to 
this sustained action, guar gum is investigated as carrier for 
Indomethacin tablets for the purpose of colon specific drug 
delivery system [4, 13]. 
7). Karaya Gum  
It is found in the form of dried gummy exudates which are 
found to obtain from the tree Sterculia urens, family 
Sterculiaceae. This gum has low solubility in water but found 
to swell many times of its original volume. The sustained 
release matrix tablet of water soluble Tramadol 
hydrochloride was formulated using various polymers like 
karaya gum and carrageenan. After the evaluation of various 
physical parameters the in vitro dissolution data was 
studied in phosphate buffer of pH 6.8, the extended release 
of drug was found to be up to 12 hours [4]. 
CONCLUSION 
Among the various routes of drug delivery the oral route is 
most preferred route for drug administration. The 
conventional dosage form offers few limitations which can 
successfully be resolved by doing modifications in the 
existing dosage form. Modified dosage forms provide helps 
in the maintaince of constant plasma drug concentration as 
well retards the release rate of drug for the long period of 
time. By optimizing or doing modifications with the help of 
polymers the various pharmacokinetics and 
pharmacodynamics parameters can be altered to provide 
sustained action. The polymers are said to be backbone of 
the pharmaceutical drug delivery system because they 
control the release of drug from the device by the act of 
diffusion, degradation and polymer swelling. The 
attractiveness towards natural gums is increasing day by 
day because they are non-toxic, biodegradable, 
biocompatible and readily available. Several polymers are 
found to be of plant origin which are satisfactorily 
investigated and used as excipients in the design and 
formulation of sustained release dosage form. These natural 
polysaccharides offers excellent potential as the carrier 
materials found in the matrix type sustained drug delivery 
system such as beads, tablets, cross linked hydrogels etc. 
These polymers are also widely used for film forming 
activities around tablet core, which leads to provide 
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sustained action of drug. Thus it is concluded that it is the 
use of polymers only which modified the release of drug and 
provides predetermined action of the drug for extended 
period of time by eliminating repeated dosing and finally 
provides reduction in the fluctuations of plasma peak profile 
of drug which ultimately leads to patient compliance as only 
one dose of sustained drug is enough for providing 
therapeutic benefit.    
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